Photo of Jeff Duncan
R United States House · District 3 · South Carolina

Rep. Jeff Duncan

Compare
Total votes
2,168
all sessions
Attendance
98%
50 missed
Near the chamber average
With party
91%
of cast votes
Near the chamber average
Bipartisan score
5%
crosses aisle rarely
Higher than 75% of chamber peers
Sponsored
949
bills & resolutions
Near the chamber average
Committees
0
assignments
949 bills and resolutions

Sponsored bills

Total
949
Primary
55
Co-sponsor
894
This page
949
matching current filters
Primary HR 777
In committee · United States House · Lead sponsor
Visa Overstay Enforcement Act of 2023

Visa Overstay Enforcement Act of 2023 This bill imposes various penalties on non-U.S. nationals ( aliens under federal law) who overstay a visa or lawful immigration status. An individual who overstays shall be fined or imprisoned for up to six months, or both. Such an individual may not be admitted into the United States for 5 years, and may not be granted a visa for 10 years. For subsequent offenses, the individual shall be fined or imprisoned for up to two years, or both, and may not be admitted into the United States or granted a visa. The Department of Homeland Security shall make case-by-case exceptions for individuals who overstay due to medical necessity, public safety, or national security reasons.

In committee Feb 2, 2023 0 co-sponsors
Primary HR 776
In committee · United States House · Lead sponsor
Build up Illegal Line Defenses with Assets Lawfully Lifted Act of 2023

Build up Illegal Line Defenses with Assets Lawfully Lifted Act of 2023 This bill directs certain amounts from the Department of Justice (DOJ) Assets Forfeiture Fund to the deployment of additional border security measures. Specifically, DOJ must report annually on the amount of total deposits into the fund that are derived from Mexican cartels. The bill makes available 50% of that amount for the construction of additional physical barriers and roads near the border to deter illegal crossings into the United States. Additionally, the bill prohibits the release of seized currency or contraband that likely belongs to or supports a foreign illegal trafficking organization while a civil forfeiture action is pending.

In committee Feb 2, 2023 0 co-sponsors
Co-sponsor HR 809
In committee · United States House · Co-sponsor
Prohibition of Agricultural Land for the People’s Republic of China Act

Prohibition of Agricultural Land for the People's Republic of China Act This bill requires the President to prohibit nonresident aliens, foreign businesses, and agents associated with China's government from (1) purchasing agricultural (including ranching) real estate located in the United States, or (2) participating in Department of Agriculture programs that are unrelated to food and safety regulatory requirements.

In committee Feb 2, 2023 1 co-sponsor
Co-sponsor HR 382
Passed · United States House · Co-sponsor
Pandemic is Over Act

Maddy summaryHR 382, the "Pandemic is Over Act," terminates the federal public health emergency declaration for the COVID-19 pandemic. The bill ends the emergency status declared on January 31, 2020, effective upon the bill's enactment. This action directly ends the federal authority tied to the emergency, including related public health measures and funding mechanisms under the Public Health Service Act.

Passed Feb 1, 2023 1 co-sponsor
Co-sponsor HR 21
Passed · United States House · Co-sponsor
Strategic Production Response Act

Maddy summaryThe Strategic Production Response Act (HR 21) requires the Secretary of Energy to develop a plan increasing oil and gas leasing on federal lands (managed by Interior, Agriculture, Energy, and Defense) by the same percentage as any initial drawdown of petroleum from the Strategic Petroleum Reserve. This plan must be created before the first sale, exchange, or loan of reserve oil, and cannot increase leasing on federal lands by more than 10% overall. The bill mandates consultation with the Secretaries of Agriculture, Interior, and Defense during plan development. It directly affects federal land management agencies and future oil/gas leasing decisions on public lands.

Passed Jan 30, 2023 1 co-sponsor
Co-sponsor HRES 48
In committee · United States House · Co-sponsor
Expressing support for the Supreme Court's decision in Dobbs v. Jackson Women's Health Organization.

This resolution expresses support for the Supreme Court's holding in Dobbs v. Jackson Women's Health Organization (that there is no constitutional right to abortion). The resolution also applauds the courage of the Justices for standing by their allegiance to the Constitution and the legitimacy of the Supreme Court, and it expresses a commitment to supporting policies that continue to protect all life.

In committee Jan 27, 2023 1 co-sponsor
Co-sponsor HR 416
In committee · United States House · Co-sponsor
Prohibiting Abortion Industry’s Lucrative Loopholes Act

Prohibiting Abortion Industry's Lucrative Loopholes Act This bill expands the prohibition on the sale or purchase of human fetal tissue in interstate commerce to include any payments associated with the transportation, implantation, processing, preservation, quality control, or storage of such tissue.

In committee Jan 27, 2023 1 co-sponsor
Co-sponsor HR 398
In committee · United States House · Co-sponsor
Protecting Life and Integrity in Research Act of 2023

Protecting Life and Integrity in Research Act of 2023 This bill restricts research that uses human fetal tissue from an induced abortion. Specifically, it prohibits the Department of Health and Human Services from conducting or supporting such research. Additionally, the bill applies requirements on the research of transplantation of fetal tissue for therapeutic purposes to research on fetal tissue in general. The bill also prohibits soliciting or acquiring a donation of human fetal tissue from an induced abortion, other than for purposes of an autopsy or burial.

In committee Jan 27, 2023 1 co-sponsor
Co-sponsor HR 427
In committee · United States House · Co-sponsor
SAVE Moms and Babies Act of 2023

Maddy summaryThis bill would prohibit the FDA from approving new abortion medications or investigational uses of existing ones. It would restrict currently approved abortion drugs to in-person administration only in clinics, hospitals, or medical offices by certified providers who can handle complications like ectopic pregnancy or severe bleeding. The law requires detailed adverse event reporting (excluding patient identifiers) to the FDA by both manufacturers and prescribers, and mandates provider certification covering pregnancy assessment, surgical intervention capabilities, and patient safety documentation. These provisions apply directly to healthcare providers, patients seeking medication abortions, and manufacturers of abortion drugs.

In committee Jan 27, 2023 1 co-sponsor
Showing 401 to 410 of 949 bills
Previous 1 … 40 41 42 … 95 Next